BELITE BIO, INC BLTE
- Tinlarebant — Stargardt Disease Type 1 NDA Submitted
- tinlarebant — Geographic Atrophy Phase 3
- LBS-009 — Non-Alcoholic Fatty Liver Disease Preclinical
- LBS-009 — Nonalcoholic Steatohepatitis Preclinical
- LBS-009 — Type 2 Diabetes Preclinical
- LBS-009 — Gout Preclinical